SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-09-033092
Filing Date
2009-05-15
Accepted
2009-05-15 17:25:38
Documents
9
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a09-11548_110q.htm 10-Q 713656
2 EX-10.13.1 a09-11548_1ex10d13d1.htm EX-10.13.1 19790
3 EX-10.19.3 a09-11548_1ex10d19d3.htm EX-10.19.3 87238
4 EX-10.48 a09-11548_1ex10d36d1.htm EX-10.36.1 163105
5 EX-10.49 a09-11548_1ex10d37d1.htm EX-10.37.1 183207
6 EX-31.1 a09-11548_1ex31d1.htm EX-31.1 13435
7 EX-31.2 a09-11548_1ex31d2.htm EX-31.2 13378
8 EX-32.1 a09-11548_1ex32d1.htm EX-32.1 5954
9 EX-32.2 a09-11548_1ex32d2.htm EX-32.2 6836
  Complete submission text file 0001104659-09-033092.txt   1208094
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 09834704
SIC: 2834 Pharmaceutical Preparations